Skip to main content

TJO Surpasses 50,000 Implants Placed, with 32% of Procedures Performed in ASCs

Milestone reflects sustained surgeon adoption of efficient joint replacement systems across hospital and ambulatory settings

Total Joint Orthopedics, Inc. (TJO), an innovator in joint replacement solutions, today announced it has surpassed 50,000 total implants placed nationwide, including more than 38,000 Klassic® Knee implants.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302099520/en/

TJO’s Klassic® Knee System: clinically proven, 38,000+ implanted, modern universal design

TJO’s Klassic® Knee System: clinically proven, 38,000+ implanted, modern universal design

In 2025, 32% of TJO procedures were performed in ambulatory surgery centers (ASCs), reflecting sustained surgeon adoption in environments where operational efficiency and procedural consistency are essential.

As joint replacement expands across sites of care and economic pressures intensify, surgeons are prioritizing systems that reduce complexity without compromising outcomes. And particularly in ambulatory environments, efficiency is operational: fewer trays and simplified workflows directly impact setup, sterilization demands, and turnover time.

TJO’s portfolio is built around an “Efficiency by Design” philosophy that prioritizes streamlined instrumentation, system consistency, and adaptability across hospital and ASC settings, without any compromise in survivorship or functional outcomes.

“Ambulatory surgery centers are now our fastest-growing primary TKA setting,” comments Erin Hofmann, TJO’s CEO. “In those environments, efficiency is imperative. Systems that simplify workflow and reduce tray burden earn their place in the OR. Surgeons stay with solutions that make their teams’ jobs easier while maintaining excellent outcomes.”

38,000 Klassic® Knees Implanted

Of the 50,000 implants, more than 38,000 have been knee procedures, driven by adoption of the Klassic® Knee System and the Klassic® Revision Knee System across hospital and ambulatory environments.

The Klassic® Knee System features the only modern universal femoral component on the market; a design that eliminates the need for left and right implants. This symmetric architecture enables streamlined instrumentation, reducing sterilization and storage burden while supporting faster setup and turnover times in high-volume ASC environments. Through the Klassic ONE® single-tray system, up to 90% of primary total knee procedures can be performed with a single instrument tray—delivering estimated per-case cost savings of up to $1,350.3-5

Ten-year clinical data on the Klassic® Knee demonstrates no compromise in survivorship or functional outcomes.1 In a comparative analysis, patient outcomes were similar across implant types, while the symmetric group demonstrated significantly improved radiographic patellar tracking, reinforcing the durability of the design philosophy.2

If you would like more information about this topic, please call 888.890.0102 or email sales@tjoinc.com.

About Total Joint Orthopedics, Inc.

Total Joint Orthopedics, Inc. (TJO) is a medical device company built to simplify joint replacement. As total joint arthroplasty moves increasingly into ambulatory surgery centers and value-driven care models, TJO’s Efficiency by Design® platform delivers long-term clinical performance through streamlined system architecture and reduced instrumentation complexity.

Its flagship Klassic® Knee System, supported by 10-year survivorship data, features a universal femoral design that eliminates left/right component redundancy and enables single-tray primary workflows. Across its portfolio, including the Klassic HD® Hip and Klassic® Revision Knee Systems, TJO requires a maximum of three instrument trays per procedure—reducing sterilization burden, improving turnover efficiency, and aligning with the economic realities of modern joint care. To learn more, please visit tjoinc.com.

References

1) Nielsen A, Law J, Homolka L, Forrester DA, Hofmann AA. Positive Clinical Outcomes at 10 Years with the Universal Femoral Component in Total Knee Arthroplasty. J Orthop. 2024 Dec 25;66:67-70. doi: 10.1016/j.jor.2024.12.026. eCollection 2025 Aug.

2) Joshua P. Rainey, MD; Brenna E. Blackburn, PhD; Claire R. Kapron; Michael J. Archibeck, MD; Lucas A. Anderson; Christopher E. Pelt, MD. Radiographic and Clinical Comparisons of a Modern Symmetrical vs. Asymmetrical Implant Design in Primary TKA. J Arthroplasty. 2025 Feb 14:S0883-5403(25)00149-4. doi: 10.1016/j.arth.2025.02.021.

3) Siegel GW, Patel NN, Milshteyn MA, et al. Cost analysis and surgical site infection rates in total knee arthroplasty comparing traditional vs. single-use instrumentation. J Arthroplasty. 2015;30(12):2271-74.

4) Watters, et al. Analysis of procedure-related costs and proposed benefits of using patient-specific approach in total knee arthroplasty. J. Surg Orth Adv. 2011.

5) Maathuis et al. Perioperative contamination in primary total hip arthroplasty. Clin Ortho Rel Res. 2005.

ASCs are now our fastest-growing primary TKA setting, and efficiency is imperative. TJO’s systems, which simplify workflow and reduce tray burden, earn their place in the OR.

Contacts

Scott Emami
Total Joint Orthopedics, Inc.
Phone: 801.486.6070
Email: semami@tjoinc.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.19
-1.81 (-0.86%)
AAPL  263.80
-0.38 (-0.14%)
AMD  195.57
-4.64 (-2.32%)
BAC  49.74
-0.09 (-0.17%)
GOOG  305.16
-6.27 (-2.01%)
META  649.65
+1.47 (0.23%)
MSFT  399.10
+6.36 (1.62%)
NVDA  180.78
+3.59 (2.03%)
ORCL  146.00
+0.60 (0.41%)
TSLA  398.20
-4.31 (-1.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.